University of Pittsburgh scientist honored for major accomplishment in cancer research

October 26, 2003

PITTSBURGH, Oct. 26 - Yuan Chang, M.D., professor of pathology at the University of Pittsburgh School of Medicine, has been awarded the Paul Marks Prize for Cancer Research by Memorial Sloan-Kettering Cancer Center for her work investigating Kaposi's sarcoma-associated herpesvirus (KSHV), the most recently discovered virus linked to human cancer.

KSHV is the cause of Kaposi's sarcoma, a common cancer among AIDS patients, and also is linked to other immune disorders including a type of B-cell lymphoma and Castleman's disease, a noncancerous but severe disorder characterized by enlargement of the lymph nodes.

Dr. Chang will share the $125,000 Marks Prize with two other scientists under the age of 45 who have made significant contributions to the basic understanding and treatment of cancer.

"Yuan Chang's discovery of KSHV was a seminal breakthrough that has enabled all subsequent understanding of how the virus causes disease, as well as the diagnosis and potential treatment of KSHV infection," said Elliott D. Kieff, M.D., Ph.D., professor of microbiology and molecular genetics at Harvard Medical School. "Her basic and clinical research has transformed our understanding of the most common malignancy in people infected with HIV."

Dr. Chang, 43, co-discovered KSHV, also known as human herpesvirus 8, along with her husband, Patrick Moore, M.D., M.P.H., professor of molecular genetics and biochemistry at the University of Pittsburgh and director of the molecular biology program at the University of Pittsburgh Cancer Institute. Prior to their discovery, Kaposi's sarcoma was believed to be caused by an infectious agent, but the cause of the disease remained unknown.

Since discovering KSHV in 1994, Dr. Chang has continued to study the biology of the virus to understand the basis for its ability to cause cancer. In 1996, she and her colleagues published the DNA sequence of KSHV, revealing that the virus has pirated several cellular genes that have proven useful in understanding the properties of other tumor viruses.

"We are studying the genes in KSHV to gain insights into the processes in cells that lead to cancer," Dr. Chang said. "The virus carries genetic material that causes cancer into cells. We are finding that the same pathways affected by these viral genes also are altered in cancers not caused by viruses," she said.

The Marks Prize, named after Paul A. Marks, president emeritus of Memorial Sloan-Kettering Cancer Center, recognizes significant contributions to the basic understanding and treatment of cancer by scientists no more than 45 years of age. The winners were selected by a committee chaired by Jeffrey M. Friedman, M.D., Ph.D., of the Rockefeller University and the Howard Hughes Medical Institute.
-end-
ADDITIONAL CONTACT:
Jocelyn Uhl
PHONE: 412-647-3555
FAX: 412-624-3184
E-MAIL: UhlJH@upmc.edu

University of Pittsburgh Medical Center

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.